Teva Pharmaceuticals USA Commits to I-many's Next Generation Enterprise Contract Management Platform; World's Leading Generic Pharmaceutical Manufacturer to Leverage I-many's New ECMF 4.0 Platform

Business Wire, May 24, 2005

EDISON, N.J. -- I-many, Inc. (NASDAQ:IMNY), a provider of advanced Enterprise Contract Management (ECM) solutions for managing corporate commitments, today announced that Teva Pharmaceuticals USA has signed a new three year agreement expanding its use of I-many solutions including I-many's new Enterprise Contract Management (ECMF) 4.0 platform and associated applications, known collectively as ContractSphere(R). This advanced solution suite will provide companies like Teva with access to a full range of integrated contract lifecycle components designed specifically for Health and Life Sciences companies, including price optimization, accrual forecasting, contract negotiation, contract creation, active compliance management, price activation, script-level data validation, Medicaid/State Supplemental Claims adjudication, Government Pricing management and tracking, Chargeback management, Rebate and Incentive management, Executive dashboards, scorecarding, reporting and analysis. ECMF's revolutionary composite architecture will provide companies with benefits including a lower total cost of ownership, advanced security model, built-in Web-service based integration (including "Powered by SAP NetWeaver(TM)" certified), multi-tenant support for the management of diverse divisions, operating companies, etc. and platform independence.

As the largest generic pharmaceutical manufacturer in the United States, Teva Pharmaceuticals USA has the broadest product lines and sales volumes as measured by units in the generic pharmaceuticals industry, with over 225 products representing more than 600 SKUs. Teva markets a wide range of products from therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Teva USA is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., which operates globally in more than 30 countries on 5 continents.

"I-many's solutions, deep domain expertise, and ability to anticipate and quickly respond to regulatory changes, commercial contracting needs and other requirements in life sciences have dramatically helped many companies like Teva to address many critical business processes related to commercial contracts, rebates, chargeback, Medicaid, state supplemental programs and government pricing," said Terry Nicholson, chief operating officer of I-many. "I-many's new platform positions Teva to take advantage of cutting-edge technology and will give them the competitive edge they need as they continue their rapid growth."

I-many ContractSphere4 for Health & Life Sciences is built on I-many's ECMF 4.0 platform, an advanced technical platform for developing, deploying and managing applications and connectivity to other applications and environments. Among other attributes, applications delivered on Contractshpere4 composite architecture are J2EE compliant and deployable either "behind the firewall" or as an "on demand" application stack for any number of distinct companies or users. With ECMF 4.0, I-many possesses the technological firepower necessary to compete with any software company in the world from a position of advantage.

"This innovative platform will revolutionize how life sciences companies like Teva manage end-to-end contract processes and regulatory requirements across all contract types in their enterprise," said Leigh Powell, president and chief executive officer of I-many. "We deeply value Teva's commitment to I-many's vision, products and new ECMF 4.0 platform and look forward to our continued partnership in the years to come."

About I-many

I-many (NASDAQ:IMNY) delivers the most advanced Enterprise Contract Management solutions for managing corporate commitments. Designed to extend beyond the traditional contract management capabilities, I-many ContractSphere(R) offers an end-to-end solution, from pre-contract processes and contract management to transaction compliance. Ultimately, this provides companies with the visibility and control needed to manage any type of commitments - from contracts and obligations to payments and collections. The result is increased revenue, minimized risk and dramatically reduced operating costs, which deliver improved profitability with hard return on investment. More than 280 customers across 21 industries worldwide have implemented and realized the value of I-many business solutions. For more information, please visit www.imany.com.

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include: the risk of unforeseen technical or practical impediments to planned software development and other risk factors set forth from time to time in the Company's filings with the Securities and Exchange Commission.